EXOZ: Converting Cell-Free Science into a Scalable and Repeatable Commercial Opportunity
eXoZymes has spent nearly a decade developing engineered enzymes and cell-free production systems designed to manufacture molecules that can be...
100 Views
Primer: eXoZymes (EXOZ US) - Aug 2026
eXoZymes Inc. (NASDAQ: EXOZ) is an emerging biotechnology pioneer commercializing an artificial intelligence-enhanced, cell-free...
98 Views
EXOZ: Key Takeaways from 2Q26 Update; From Platform Validation to Commercial Execution
This month, eXoZymes announced that its optimized NCT (a metabolism-boosting compound previously inaccessible at scale) process delivered ~10x...
98 Views
WTR Healthcare Happenings Podcast Recap : EXoZymes
On the latest WTR Healthcare Happenings podcast, we were joined by CEO Michael Heltzen of eXoZymes, Inc. (NASDAQ: EXOZ), a pioneering AIenhanced...
134 Views
No more insights